|
AMD1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.707600E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.304030E-02 |
| Normal-vs-Stage2 |
8.211400E-01 |
| Normal-vs-Stage3 |
1.570240E-02 |
| Normal-vs-Stage4 |
4.86340000049879E-07 |
| Stage1-vs-Stage2 |
1.462780E-01 |
| Stage1-vs-Stage3 |
4.40130000000094E-05 |
| Stage1-vs-Stage4 |
4.12469947086436E-10 |
| Stage2-vs-Stage3 |
1.967410E-01 |
| Stage2-vs-Stage4 |
1.000460E-02 |
| Stage3-vs-Stage4 |
4.195700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.399600E-01 |
| Normal-vs-AfricanAmerican |
4.421000E-01 |
| Normal-vs-Asian |
8.521800E-02 |
| Caucasian-vs-AfricanAmerican |
3.592800E-01 |
| Caucasian-vs-Asian |
5.032000E-01 |
| AfricanAmerican-vs-Asian |
1.482630E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.810390E-01 |
| Normal-vs-Female |
1.081570E-01 |
| Male-vs-Female |
1.034130E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.397600E-01 |
| Normal-vs-Age(41-60Yrs) |
5.528000E-01 |
| Normal-vs-Age(61-80Yrs) |
6.480800E-01 |
| Normal-vs-Age(81-100Yrs) |
5.645800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.717200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.124400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.650400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.721800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.274600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.382200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.656400E-01 |
| Normal-vs-Grade 2 |
2.716800E-03 |
| Normal-vs-Grade 3 |
2.732000E-02 |
| Normal-vs-Grade 4 |
1.69960046036977E-10 |
| Grade 1-vs-Grade 2 |
9.828400E-01 |
| Grade 1-vs-Grade 3 |
5.488500E-02 |
| Grade 1-vs-Grade 4 |
5.578000E-03 |
| Grade 2-vs-Grade 3 |
1.5255799999947E-05 |
| Grade 2-vs-Grade 4 |
1.6743273434372E-12 |
| Grade 3-vs-Grade 4 |
3.778100000007E-05 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.026800000003E-05 |
| Normal-vs-ccB subtype |
9.937600E-02 |
| ccA subtype-vs-ccB subtype |
1.72536999999418E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.791600E-01 |
| Normal-vs-N1 |
4.285600E-02 |
| N0-vs-N1 |
1.050790E-01 |
|
|
